Colombia’s Superintendence for Industry and Commerce (SIC) has issued a fine to Chilean drug-store chain Cruz Verde after the company jacke dup the price of 56 separate medications by up to 3000%, far beyond the maximum prices set by the country’s authorities.
Colombian authorities settled on fines for Cruz Verde totalling approximately $84,500 USD. Colombian media has reported that the pharmacy has already begun the process of appealing the fine, arguing that their chain has always respected the price limits set forth by the country’s guidelines.
Cruz Verde was embroiled in a similar price-fixing scheme in Chile between 2007 and 2008 in conjunction with fellow drug-store chains Farmacias Ahumada and Salcobrand, with the firm paying a total of 13 million pesos to Chile’s government.
Full Content: El Ciudadano
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Mexican Lawmakers Advance Controversial Plan to Dissolve Independent Oversight Bodies
Jan 2, 2025 by
CPI
Motorola Accuses UK of Antitrust Breach Over Terminated Emergency Services Contract
Jan 2, 2025 by
CPI
Amazon Must Face Antitrust Case Over Alleged Monopoly Practices
Jan 2, 2025 by
CPI
US Appeals Court Blocks FCC’s Move to Reinstate Net Neutrality Rules
Jan 2, 2025 by
CPI
Nvidia’s $700 Million Buyout of Run:ai Gets EU Approval, Deal Finalized
Jan 1, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand